GRIK2 and prostate carcinoma: The TRMT11-GRIK2 fusion transcript was identified in the MD-MB-231breast cancer cell line and H1299 lung cancer cell line, while CCNH-C5orf30 was positive in 14 of 20 cancer cell lines, including all the prostate cancer cell lines tested (PC3, DU145, LNCaP and VCaP), 3 of 4 breast cancer cell lines (MCF7, VACC-3133 and MDA-MB330), 2 of 4 lung cancer cell lines (H358 and H522), 1 of 3 liver cancer cell lines (HepG2), 1 of 2 colon cancer cell lines (HCT8) and 3 of 3 GBM cell lines (LN229, U138 and A-172).